EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decoding Senescence‐Driven Heterogeneity in Early‐Onset Colorectal Cancer for Prognostic and Therapeutic Stratification

Du Cai, Mingru Mai iD, Rende Huang, Haoning Qi, Xingzhi Feng, Qianling Gao, Yinmeng Zhang, Chenghang Li, Xiaojian Wu, Yize Mao, Zihuan Yang, Feng Gao

Cancer Science · 2026-03 · 117 (3) · 818-835

DOI: 10.1111/cas.70301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 28.12.2025. Verfasst von Du Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cellular Senescence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangzhou Basic and Applied Basic Research Fund, Postdoctoral Fellowship Program of CPSF, Guangdong Key Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early‐onset colorectal cancer (EOCRC), diagnosed in patients under 50, is particularly aggressive, yet lacks targeted therapeutic strategies. This study aimed to explore the role of cellular senescence in driving EOCRC's malignancy and developed a senescence scoring system (EO‐Senscore) to guide precision oncology. Through a multi‐omics analysis of 2961 patients, we discovered that cellular senescence is more pronounced and varied in EOCRC and is not tied to chronological age. Two distinct senescence subtypes were identified: Cluster 1 (low‐senescence tumors) showed prolonged survival, enhanced immunogenicity, and cell cycle activation, while Cluster 2 (high‐senescence tumors) exhibited aggressive phenotypes and an immunosuppressive microenvironment. We further developed a machine learning model, the EO‐Senscore, to quantify a tumor's senescence level. This score effectively stratified patients by prognosis and potential treatment response. Patients with a low EO‐Senscore were predicted to respond well to immunotherapy and chemotherapy. In contrast, those with a high score had more invasive tumors but showed significant sensitivity to senolytic drugs (like ABT‐263) in lab‐based experiments. In conclusion, this research establishes cellular senescence as a crucial factor in EOCRC's aggressiveness. The EO‐Senscore provides a practical, quantitative tool to guide clinical decisions, suggesting that patients could be directed toward immunotherapy or novel senolytic‐based combination therapies for more personalized and effective cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCellular SenescenceHumansPrognosisFemaleMaleMiddle AgedTumor MicroenvironmentAdultAge of OnsetMachine LearningImmunotherapySulfonamidesAniline Compounds

Stichwörter der Autor:innen

cellular senescenceearly‐onset colorectal cancerpersonalized therapyprognostic modeltumor microenvironment

Substanzen

navitoclaxSulfonamidesAniline Compounds

Autor:innen und Institutionen

  • Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of Gastroenterology and Endoscopy Center, The First Hospital of Jilin University, Jilin, China.
  • Shenzhen Peking University Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China.
  • Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.

ORCID-Profile: Mingru Mai

Förderung

  • Guangzhou Basic and Applied Basic Research Fund
  • Postdoctoral Fellowship Program of CPSF
  • Guangdong Key Research and Development Project
  • "Tianshan Talents · Leading Medical Talents in Guangdong Province" Cooperative Expert Studio
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Medical Research Special Project
  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Cai, D., Mai, M., Huang, R., Qi, H., Feng, X., Gao, Q., Zhang, Y., Li, C., Wu, X., Mao, Y., Yang, Z., & Gao, F. (2026). Decoding Senescence‐Driven Heterogeneity in Early‐Onset Colorectal Cancer for Prognostic and Therapeutic Stratification. Cancer Science, 117(3), 818-835. https://doi.org/10.1111/cas.70301

Vancouver

Cai D, Mai M, Huang R, Qi H, Feng X, Gao Q, et al. Decoding Senescence‐Driven Heterogeneity in Early‐Onset Colorectal Cancer for Prognostic and Therapeutic Stratification. Cancer Science. 2026;117(3):818-835. doi:10.1111/cas.70301

BibTeX
@article{Cai2026,
  author = {Cai, Du and Mai, Mingru and Huang, Rende and Qi, Haoning and Feng, Xingzhi and Gao, Qianling and Zhang, Yinmeng and Li, Chenghang and Wu, Xiaojian and Mao, Yize and Yang, Zihuan and Gao, Feng},
  title = {Decoding Senescence‐Driven Heterogeneity in Early‐Onset Colorectal Cancer for Prognostic and Therapeutic Stratification},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {3},
  pages = {818--835},
  doi = {10.1111/cas.70301}
}
Kostenlos starten →